SEVERANCE AGREEMENTSeverance Agreement • March 12th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT (this “Agreement”) is made and entered into this _____ day of _________ 20___ (the “Effective Date”), by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and [______________] (the “Executive”).
CTI BIOPHARMA CORP. RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • March 12th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionTHIS RESTRICTED STOCK AWARD AGREEMENT (the “Award Agreement”) is dated as of [___________, 20__] (the “Grant Date”) by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and [______________] (the “Participant”).
CTI BIOPHARMA CORP. RESTRICTED STOCK UNIT AWARD AGREEMENT (GLOBAL FORM)Restricted Stock Unit Award Agreement • March 12th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionTHIS RESTRICTED STOCK UNIT AWARD AGREEMENT, including any country-specific appendices attached hereto, (collectively the “Award Agreement”) is dated as of [___________, 20__] (the “Grant Date”) by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and [______________] (the “Participant”).
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 12th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • California
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionThis SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of October 22, 2014 (the “Second Amendment Date”), is by and among CTI BIOPHARMA CORP., formerly known as CELL THERAPEUTICS, INC., a Washington corporation (“CTI”), and SYSTEMS MEDICINE LLC, a Delaware limited liability company (“Systems Medicine”; CTI and Systems Medicine are hereinafter referred to individually and collectively, jointly and severally, as “Borrower”), HERCULES CAPITAL FUNDING TRUST 2012-1 (the “Trust”) and HERCULES TECHNOLOGY GROWTH CAPITAL, INC., a Maryland corporation (“HTGC”).
AMENDMENT NO. 2 to EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations
Contract Type FiledMarch 12th, 2015 Company IndustryTHIS AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (this “Amendment”) is dated as of January 6, 2015, by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and James A. Bianco (the “Executive”).
CTI BIOPHARMA CORP. STOCK OPTION AGREEMENT (GLOBAL FORM)Stock Option Agreement • March 12th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT, including any country-specific appendices attached hereto, (collectively the “Option Agreement”) is dated as of [____________, 20__] (the “Grant Date”) by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and [___________________] (the “Participant”). Capitalized terms used herein and not otherwise defined shall have the meaning assigned to such terms in the Plan.